Marco Tangelder Selected Research

Vitamin K

9/2004

Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Tangelder Research Topics

Disease

3	Hemorrhage 04/2018 - 06/2013
1	Peripheral Arterial Disease 04/2018
1	Hemophilia B (Haemophilia B) 01/2018
1	Venous Thromboembolism 06/2013
1	Carotid Stenosis (Carotid Artery Stenosis) 09/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2004
1	Embolism (Embolus) 09/2004
1	Peripheral Arterial Occlusive Disease 1 09/2004
1	Intermittent Claudication 09/2004
1	Ischemia 09/2004
1	Thrombosis (Thrombus) 09/2004

Drug/Important Bio-Agent (IBA)

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2018 - 09/2004
1	Clopidogrel (Plavix)FDA Link 04/2018
1	edoxabanIBA 04/2018
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2018
1	Factor VIII (Coagulation Factor VIII)IBA 06/2013
1	TB 402IBA 06/2013
1	Monoclonal AntibodiesIBA 06/2013
1	RivaroxabanIBA 06/2013
1	Vitamin K FDA Link 09/2004
1	Cilostazol (Pletal)FDA LinkGeneric 09/2004
1	AnticoagulantsIBA 09/2004
1	Heparin (Liquaemin)FDA LinkGeneric 09/2004

Therapy/Procedure

2	Therapeutics 04/2018 - 09/2004
1	Hip Replacement Arthroplasty (Total Hip Replacement) 06/2013
1	Knee Replacement Arthroplasty (Total Knee Replacement) 06/2013
1	Thrombolytic Therapy 09/2004
1	Catheters 09/2004